HSTM(HSTM)
HSTM
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $329M | $344M | $361M |
| Low | $329M | $342M | $360M |
| High | $329M | $345M | $363M |
| EBITDA Avg | $68M | $71M | $75M |
| Low | $68M | $71M | $74M |
| High | $68M | $71M | $75M |
| EBIT Avg | $21M | $22M | $23M |
| Low | $21M | $22M | $23M |
| High | $21M | $22M | $23M |
| Net Income Avg | $22M | $25M | — |
| Low | $22M | $24M | — |
| High | $23M | $25M | — |
| EPS Avg | $0.74 | $0.82 | — |
| Low | $0.73 | $0.81 | — |
| High | $0.75 | $0.82 | — |
| Analysts (Rev / EPS) | 4 / 2 | 4 / 3 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $82M | $83M | $84M | $86M | $86M | $87M |
| Low | $82M | $83M | $84M | $86M | $86M | $87M |
| High | $82M | $83M | $85M | $87M | $86M | $87M |
| EBITDA Avg | $17M | $17M | $17M | $18M | $18M | $18M |
| Low | $17M | $17M | $17M | $18M | $18M | $18M |
| High | $17M | $17M | $18M | $18M | $18M | $18M |
| EBIT Avg | $5M | $5M | $5M | $5M | $5M | $5M |
| Low | $5M | $5M | $5M | $5M | $5M | $5M |
| High | $5M | $5M | $5M | $6M | $5M | $6M |
| Net Income Avg | $5M | $5M | $6M | $7M | $6M | $6M |
| Low | $5M | $5M | $6M | $7M | $6M | $6M |
| High | $5M | $5M | $6M | $7M | $6M | $7M |
| EPS Avg | $0.17 | $0.17 | $0.20 | $0.23 | $0.21 | $0.22 |
| Low | $0.16 | $0.17 | $0.20 | $0.23 | $0.21 | $0.22 |
| High | $0.17 | $0.17 | $0.21 | $0.23 | $0.22 | $0.22 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |